Pharma Focus Asia
KP - Sustainable Packaging Solutions

QuVa Pharma Announces Pharma Facility Expansion


QuVa Pharma has announced expansion plans of its biotech pharmaceutical manufacturing facility in Bloomsbury, New Jersey.


This expansion will increase QuVa Pharma's production and distribution capabilities at the New Jersey site.

QuVa Pharma's existing manufacturing plant in Bloomsbury is an FDA 503B registered facility covering an area of 160,000 square-foot, featuring two interconnected buildings, with future expansion into a state-of-the-art 240,000 square feet facility by improving the cleanroom.

The facility expansion will be cGMP compliant and added with operation capacity for running a second shift.

Moreover, the facility will help to serve customers with a wide range of ready-to-use compounded sterile medications sourced from various starting materials such as FDA-approved pharmaceutical formulations  and active pharmaceutical ingredients and will also supply medicine during a drug shortage.

The current phase of the expansion will be completed by the fourth quarter of 2019, while the entire expansion project is expected to be completed by 2020.


NameQuVa Pharma
LocationNew Jersey
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?